Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-07-20 Sale |
2022-07-21 7:12 pm |
Allovir Inc. | ALVR | Sinha Vikas See Remarks |
1,432 | $5.2145 | $7,467 | 14,359,194 (Indirect Direct) |
View |
| 2022-04-20 Sale |
2022-04-22 08:29 am |
Allovir Inc. | ALVR | Sinha Vikas See Remarks |
1,162 | $6.6843 | $7,767 | 14,327,603 (Indirect Direct) |
View |
| 2022-01-20 Sale |
2022-01-24 4:15 pm |
Allovir Inc. | ALVR | Sinha Vikas See Remarks |
6,450 | $8.7526 | $56,454 | 14,279,927 (Indirect Direct) |
View |
| 2021-05-04 Sale |
2021-05-05 5:05 pm |
Verona Pharma plc | VRNA | Sinha Vikas Director |
10,016 | $0.8397 | $8,410 | 74,440 (Direct) |
View |
| 2021-02-01 Sale |
2021-02-03 7:11 pm |
Verona Pharma plc | VRNA | Sinha Vikas Director |
10,224 | $0.9938 | $10,161 | 84,456 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-07-28 Option Award |
2022-08-01 4:38 pm |
N/A N/A |
Allovir Inc. | ALVR | Sinha Vikas See Remarks 10% Owner |
3,253,796 | $4.61 | 17,612,990 (Indirect) |
View |
| 2022-07-01 Option Award |
2022-07-06 07:30 am |
N/A 2032-07-01 |
Allovir Inc. | ALVR | Sinha Vikas See Remarks |
84,000 | $0 | 14,415,226 (Direct) |
View |
| 2022-04-28 Option Award |
2022-04-29 4:48 pm |
N/A 2032-04-27 |
Verona Pharma plc | VRNA | Sinha Vikas Director |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-01-18 Option Award |
2022-04-04 4:25 pm |
N/A 2032-01-18 |
Allovir Inc. | ALVR | Sinha Vikas See Remarks |
168,000 | $0 | 14,447,927 (Direct) |
View |
| 2021-08-09 Option Award |
2021-08-10 4:47 pm |
N/A 2031-08-08 |
Verona Pharma plc | VRNA | Sinha Vikas Director |
64,000 | $0 | 64,000 (Direct) |
View |
| 2021-01-19 Option Award |
2021-01-21 7:27 pm |
N/A 2031-01-19 |
Allovir Inc. | ALVR | Sinha Vikas See Remarks |
168,000 | $0 | 14,395,577 (Direct) |
View |
Ownership |
2021-01-04 8:29 pm |
N/A N/A |
Verona Pharma plc | VRNA | Sinha Vikas Director |
0 | $0 | 215,064 (Direct) |
View |
Ownership |
2020-10-22 06:05 am |
N/A N/A |
BCLS Acquisition Corp. | BLSA | Sinha Vikas Director |
0 | $0 | 30,000 (Direct) |
View |
| 2020-08-03 Conversion |
2020-08-05 9:57 pm |
N/A N/A |
Allovir Inc. | ALVR | Sinha Vikas See Remarks 10% Owner |
33,420,970 | $0 | 14,227,577 (Indirect) |
View |
| 2020-07-29 Option Award |
2020-07-31 6:40 pm |
N/A 2030-07-29 |
Allovir Inc. | ALVR | Sinha Vikas See Remarks 10% Owner |
436,900 | $0 | 436,900 (Direct) |
View |
Ownership |
2020-07-30 07:52 am |
N/A N/A |
Allovir Inc. | ALVR | Sinha Vikas See Remarks 10% Owner |
0 | $0 | 14,227,577 (Direct) |
View |